Online Ketamine Treatment Available in: AZ, CA, CO, FL, GA, NY, OR, TX, and WA.
Online Ketamine Treatment Available in: AZ, CA, CO, FL, GA, NY, OR, TX, and WA.
Most ketamine research focuses on the drug in isolation — a single infusion, standardized dose, clinical rating scale at 24 hours. But in practice, many patients receive ketamine alongside psychotherapy, a model known as ketamine-assisted psychotherapy (KAP). The question of whether this combination produces better real-world outcomes than ketamine alone is difficult to answer with existing randomized trials. A 2019 study from three large KAP practices provided some of the most detailed outcome data available on this integrated approach.
Jennifer Dore and colleagues published a retrospective analysis in the Journal of Psychoactive Drugs in 2019, examining clinical data from 235 patients treated with ketamine-assisted psychotherapy across three established practices. Patients received sublingual ketamine lozenges (the most common at-home formulation) in conjunction with psychotherapy sessions. Diagnoses varied and included depression, anxiety, PTSD, and other conditions.
The study assessed outcomes using validated instruments including the Patient Health Questionnaire (PHQ-9) for depression, the Generalized Anxiety Disorder scale (GAD-7) for anxiety, and other measures. The results showed clinically meaningful and statistically significant reductions in both depression and anxiety scores over the course of treatment. Approximately 65% of patients showed a response (50% or greater improvement) in depressive symptoms, and similar rates of improvement were observed for anxiety.
Importantly, this was a practice-based study rather than a controlled trial. There was no placebo or comparator group, which limits causal conclusions. However, the large sample size, use of standardized outcome measures, and multi-site design provide a level of evidence that goes beyond individual case reports. The study also documented a favorable safety profile, with no serious adverse events reported.
From a clinician's perspective, the Dore et al. study is valuable because it reflects how ketamine is actually used in practice — not as a standalone pharmacological intervention, but as part of an integrated treatment model that includes psychotherapeutic support. The KAP framework typically involves preparation sessions before dosing, guided or supported ketamine experiences, and integration sessions afterward in which patients process their experiences with a therapist.
The rationale for this approach draws on ketamine's neuroplasticity-enhancing properties. If ketamine opens a window of enhanced synaptic flexibility, then psychotherapy conducted during this window may be more effective at reshaping maladaptive thought patterns, processing traumatic material, and building new coping strategies. While this hypothesis has not been tested in a head-to-head randomized trial comparing KAP to ketamine alone, the practice-based evidence from Dore et al. suggests the combination produces robust outcomes.
The study also highlights the diversity of conditions treated with KAP in clinical practice. While most randomized trials focus on a single diagnosis, real-world patients often present with multiple overlapping conditions. The finding that KAP produced improvements across depression, anxiety, and other domains is consistent with ketamine's broad-spectrum mechanism of action.
If you are considering ketamine therapy, the Dore et al. data suggests that integrating psychotherapy with your ketamine treatment may enhance outcomes. This doesn't mean ketamine without therapy is ineffective — there is strong evidence for ketamine's standalone antidepressant properties. But the combination appears to offer additional benefit, particularly for patients dealing with complex or trauma-related conditions.
In practice, KAP can take many forms. Some patients work with a therapist who is present during their ketamine sessions. Others have preparation and integration sessions with a therapist before and after at-home ketamine use. The key is that the therapeutic relationship provides a container for processing the emotional and psychological material that ketamine sessions often surface.
A retrospective analysis of 235 patients across three practices found that ketamine-assisted psychotherapy produced significant reductions in depression and anxiety with a favorable safety profile. While controlled trials comparing KAP to ketamine alone are still needed, this real-world evidence supports the integration of psychotherapy with ketamine treatment.
Reference: Dore J, Turnipseed B, Dwyer S, et al. "Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy." Journal of Psychoactive Drugs. 2019;51(2):189-198. PMID: 30917760
If you're considering ketamine therapy, Isha Health offers physician-led at-home treatment via telemedicine in California, New York, Texas, Florida, Colorado, Arizona, Georgia, Oregon, and Washington. No in-person visit required.
